false
Hamburger Menu
Catalog
Antibody Drug Conjugates (ADCs) in NSCLC
Antibody Drug Conjugates (ADCs) in NSCLC
Podcast | English | 2022 | 39 Min
Create Account
Credit
No Credit Offered
Summary
What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen Liu is joined by Dr. Rebecca Heist, associate director of clinical research at Massachusetts General Hospital Cancer Center in Boston, and Dr. Ben Levy, clinical director of medical oncology at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center in Baltimore.
Faculty
Podcast Hosts:
Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA
Podcast Guests:
Rebecca Heist, MD, Associate Professor of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
Ben Levy, MD, Associate Professor, Johns Hopkins School of Medicine, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA
×
Antibody Drug Conjugates (ADCs) in NSCLC Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English